Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Results In this study, all of the 90 participants were subjected to reduced GSH level evaluation and the results are shown in Figure 1
The most recent large series by Ghaith et al
ESC Heart Fail 5(6):10351043 Lepore JJ, Olson E, Demopoulos L, Haws T, Fang Z, Barbour AM, Fossler M, Davila-Roman VG, Russell SD, Gropler RJ (2016) Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction
Pharmacokinetic Profile Route of Administration Subcutaneous Route of Administration : Subcutaneous Injection Formulation & Handling Supplied as a sterile, lyophilized powder Reconstitute with sterile water or buffer as per laboratory protocol Store lyophilized at -20C
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
